Price$20.80+2.44 (+13.26%)
2026-01-202026-04-23
News · 26 weeks83-29%
2025-10-262026-04-19
Mix5090d
- Insider17(34%)
- Other15(30%)
- SEC Filings15(30%)
- Earnings2(4%)
- Analyst1(2%)
Latest news
25 items- SECAmendment: SEC Form SCHEDULE 13D/A filed by Core Scientific Inc.SCHEDULE 13D/A - Core Scientific, Inc./tx (0001839341) (Subject)
- PRCore Scientific Announces Pricing of $3.3 Billion of Senior Secured NotesCore Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or the "Company"), a leader in digital infrastructure for high-density colocation ("HDC"), today announced that its wholly-owned subsidiary, Core Scientific Finance I LLC (the "Issuer"), has priced an offering of $3.3 billion aggregate principal amount of 7.750% senior secured notes due 2031 (the "Notes") at an issue price equal to 99.250% of the principal amount thereof. The Notes will be sold in a private offering to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to non-U.S. persons outside of the United States pursuant
- INSIDERSEC Form 4 filed by Duchene Todd M4 - Core Scientific, Inc./tx (0001839341) (Issuer)
- SECCore Scientific Inc. filed SEC Form 8-K: Regulation FD Disclosure8-K - Core Scientific, Inc./tx (0001839341) (Filer)
- PRCore Scientific Announces Proposed Offering of $3.3 Billion of Senior Secured NotesCore Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or the "Company"), a leader in digital infrastructure for high-density colocation ("HDC"), today announced that its wholly-owned subsidiary, Core Scientific Finance I LLC (the "Issuer"), intends to offer, subject to market conditions and other factors, $3.3 billion aggregate principal amount of senior secured notes due 2031 (the "Notes"), in a private offering to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to non-U.S. persons outside of the United States pursuant to Regulation S under the Securities Act. The Issuer in
- INSIDERSEC Form 4 filed by Duchene Todd M4 - Core Scientific, Inc./tx (0001839341) (Issuer)
- INSIDERSEC Form 4 filed by Sullivan Adam Taylor4 - Core Scientific, Inc./tx (0001839341) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Core Scientific Inc.SCHEDULE 13D/A - Core Scientific, Inc./tx (0001839341) (Subject)
- INSIDERSEC Form 4 filed by Duchene Todd M4 - Core Scientific, Inc./tx (0001839341) (Issuer)
- INSIDERSEC Form 4 filed by Duchene Todd M4 - Core Scientific, Inc./tx (0001839341) (Issuer)
- INSIDERSEC Form 4 filed by Sullivan Adam Taylor4 - Core Scientific, Inc./tx (0001839341) (Issuer)
- INSIDERSEC Form 4 filed by Duchene Todd M4 - Core Scientific, Inc./tx (0001839341) (Issuer)
- SECSEC Form 144 filed by Core Scientific Inc.144 - Core Scientific, Inc./tx (0001839341) (Subject)
- SECSEC Form DEFA14A filed by Core Scientific Inc.DEFA14A - Core Scientific, Inc./tx (0001839341) (Filer)
- SECSEC Form DEF 14A filed by Core Scientific Inc.DEF 14A - Core Scientific, Inc./tx (0001839341) (Filer)
- INSIDERAmendment: SEC Form 4 filed by Nygaard James P Jr4/A - Core Scientific, Inc./tx (0001839341) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Core Scientific Inc.SCHEDULE 13G/A - Core Scientific, Inc./tx (0001839341) (Subject)
- SECCore Scientific Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits8-K - Core Scientific, Inc./tx (0001839341) (Filer)
- PRCore Scientific Expands Strategic Financing Facility to $1 Billion with Additional $500 Million Commitment from J.P. MorganCore Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or the "Company"), a leader in digital infrastructure for high-density colocation, today announced that it closed an additional $500 million commitment provided by JPMorgan Chase Bank, N.A. under the accordion feature of the Company's previously announced 364-day credit facility (the "Facility"). This brings total funded commitments under the Facility to $1.0 billion, including the previously announced $500 million commitment from Morgan Stanley. Borrowings under the Facility bear interest at a rate of the Secured Overnight Financing Rate ("SOFR") plus 250 basis points (2.50%). "We are proud to have commitments from Morgan Stanley and
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Core Scientific Inc.SCHEDULE 13D/A - Core Scientific, Inc./tx (0001839341) (Subject)
- INSIDERSEC Form 4 filed by Nygaard James P Jr4 - Core Scientific, Inc./tx (0001839341) (Issuer)
- SECAmendment: SEC Form 10-K/A filed by Core Scientific Inc.10-K/A - Core Scientific, Inc./tx (0001839341) (Filer)
- SECSEC Form SCHEDULE 13G filed by Core Scientific Inc.SCHEDULE 13G - Core Scientific, Inc./tx (0001839341) (Subject)
- INSIDERDirector Weiss Eric Stanton bought $101,700 worth of shares (7,000 units at $14.53), increasing direct ownership by 3% to 252,262 units (SEC Form 4)4 - Core Scientific, Inc./tx (0001839341) (Issuer)
- PRCadillac Formula 1® Team Joins Forces with Core Scientific as Official Data Center PartnerCore Scientific and Cadillac Formula 1® Team Announce a Multi-Year Global Partnership Core Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or the "Company"), a leader in digital infrastructure for high-density colocation, and Cadillac Formula 1® Team have announced a multi-year global partnership, naming Core Scientific as the team's Official Data Center Partner. Core Scientific will play a central role in advising and shaping the team's data center infrastructure in its new U.S. headquarters, currently under construction in Indianapolis, Indiana. Through this partnership, Core Scientific will provide strategic consulting, architectural guidance and optimization expertise to ensure th